Hickey, Christopher M.
Digianantonio, Katherine M.
Zimmermann, Kurt http://orcid.org/0009-0003-3420-9451
Harbin, Alicia
Quinn, Connor
Patel, Avani
Gareiss, Peter http://orcid.org/0009-0009-6738-2414
Chapman, Amanda
Tiberi, Bernadette
Dobrodziej, Jennifer
Corradi, John
Cacace, Angela M.
Langley, David R.
Békés, Miklós http://orcid.org/0000-0001-8423-9235
Article History
Received: 14 April 2023
Accepted: 4 October 2023
First Online: 4 January 2024
Competing interests
: All authors are, or have been, employees and shareholders of Arvinas Inc, which is developing PROTAC molecules for therapeutic applications.